Volterra Technologies LP Acquires Shares of 3,629 CME Group Inc. $CME

Posted by Joseph Griffin on Jul 24th, 2026

Volterra Technologies LP bought a new stake in CME Group Inc. (NASDAQ:CME – Free Report) in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 3,629 shares of the financial services provider’s stock, valued at approximately $1,072,000.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Empowered Funds LLC raised its holdings in CME Group by 11.5% during the 1st quarter. Empowered Funds LLC now owns 10,027 shares of the financial services provider’s stock worth $2,660,000 after purchasing an additional 1,037 shares during the last quarter. Marshall Wace LLP lifted its position in CME Group by 103.1% during the 2nd quarter. Marshall Wace LLP now owns 3,692 shares of the financial services provider’s stock valued at $1,018,000 after purchasing an additional 121,707 shares during the period. Federated Hermes Inc. boosted its stake in shares of CME Group by 1,325.2% in the 2nd quarter. Federated Hermes Inc. now owns 23,572 shares of the financial services provider’s stock valued at $6,497,000 after purchasing an additional 21,918 shares during the last quarter. Nebula Research & Development LLC bought a new position in shares of CME Group in the 2nd quarter valued at about $992,000. Finally, The Manufacturers Life Insurance Company grew its position in shares of CME Group by 2.6% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 287,876 shares of the financial services provider’s stock worth $79,344,000 after buying an additional 7,397 shares during the period. Institutional investors own 87.75% of the company’s stock.

Insider Activity

In related news, CEO Terrence A. Duffy sold 35,000 shares of the company’s stock in a transaction on Friday, May 15th. The shares were sold at an average price of $298.51, for a total value of $10,447,850.00. Following the completion of the sale, the chief executive officer owned 55,630 shares in the company, valued at $16,606,111.30. This represents a 38.62% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider Hilda Harris Piell sold 5,753 shares of the firm’s stock in a transaction on Monday, May 18th. The stock was sold at an average price of $304.63, for a total value of $1,752,536.39. Following the sale, the insider directly owned 27,702 shares in the company, valued at $8,438,860.26. The trade was a 17.20% decrease in their position. The SEC filing for this sale provides additional information. 0.30% of the stock is owned by company insiders.

CME Group Stock Up 2.0%

CME Group stock opened at $254.32 on Friday. The firm has a market capitalization of $92.16 billion, a price-to-earnings ratio of 21.57, a PEG ratio of 3.10 and a beta of 0.25. The company’s 50 day simple moving average is $255.00 and its 200 day simple moving average is $281.41. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. CME Group Inc. has a fifty-two week low of $218.31 and a fifty-two week high of $329.16.

CME Group (NASDAQ:CME – Get Free Report) last issued its earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 EPS for the quarter, beating the consensus estimate of $2.91 by $0.08. The firm had revenue of $1.71 billion during the quarter, compared to the consensus estimate of $1.68 billion. CME Group had a net margin of 63.30% and a return on equity of 15.60%. The business’s quarterly revenue was up .8% on a year-over-year basis. During the same quarter in the prior year, the firm earned $2.96 earnings per share. As a group, sell-side analysts anticipate that CME Group Inc. will post 12.17 EPS for the current year.

CME Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, June 25th. Stockholders of record on Tuesday, June 9th were issued a $1.30 dividend. The ex-dividend date of this dividend was Tuesday, June 9th. This represents a $5.20 annualized dividend and a dividend yield of 2.0%. CME Group’s payout ratio is 44.11%.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on the stock. Wall Street Zen downgraded shares of CME Group from a “hold” rating to a “sell” rating in a research note on Sunday, July 12th. Jefferies Financial Group reduced their price objective on shares of CME Group from $356.00 to $349.00 and set a “buy” rating on the stock in a research note on Thursday, April 9th. JPMorgan Chase & Co. increased their price target on CME Group from $249.00 to $250.00 and gave the company an “underweight” rating in a research note on Thursday. Deutsche Bank Aktiengesellschaft reduced their price target on CME Group from $342.00 to $322.00 and set a “buy” rating on the stock in a research report on Thursday, April 23rd. Finally, Keefe, Bruyette & Woods raised CME Group from a “market perform” rating to an “outperform” rating and set a $305.00 price objective for the company in a research note on Thursday, June 18th. Eleven investment analysts have rated the stock with a Buy rating, four have given a Hold rating and three have issued a Sell rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $291.81.

Get Our Latest Research Report on CME Group

More CME Group News

Here are the key news stories impacting CME Group this week:

Positive Sentiment: CME Group beat Q2 estimates, reporting $2.99 EPS versus $2.91 expected and revenue of about $1.71 billion versus $1.68 billion expected, supporting the stock. CME profit tops estimates, CEO says ‘perps’ chatter overshadows results
Positive Sentiment: Management said the first half of 2026 was the strongest in company history for revenue, adjusted operating income, adjusted net income, and adjusted diluted EPS, which likely boosted investor confidence. CME Group jumps after Q2 earnings beat and strong trading activity
Positive Sentiment: Record market data revenue and strong trading volumes suggested core business momentum remains healthy, another bullish catalyst for the stock. CME Group jumps after Q2 earnings beat and strong trading activity
Neutral Sentiment: UBS reiterated a Hold rating with a $260 target, signaling solid fundamentals but limited upside from current levels. Neutral Stance Reiterated on CME as Solid Fundamentals Meet Valuation Limits; $260 Price Target Maintained
Negative Sentiment: JPMorgan kept an Underweight rating and BofA maintained an Underperform stance, both implying analysts still see downside risk despite the earnings beat. Benzinga report on JPMorgan price target change Benzinga report on Bank of America price target change

About CME Group

(Free Report)

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.